EUCLID
July 6, 2024PEGASUS
July 6, 2024EUCLID
July 6, 2024PEGASUS
July 6, 2024EUCLID
July 6, 2024PEGASUS
July 6, 2024A multinational, randomised, double-blind, placebo-controlled phase IIIb trial to evaluate the effect of ticagrelor twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus
Read Study